SHARED CARE AGREEMENT Atomoxetine as a single agent non-stimulant (not for combination) Clinical Indication: For Children (aged 6 years and over) and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) Version: 2 Approval date: November...
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.fifeadtc.scot.nhs.uk/media/36100/atomoxetine-sca-updated-november-2021.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
